Sarah Baker, MD
Colon & Rectal Surgery · Marrero, LANPI 1134482706
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 74.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $8,178 and has fallen 96.5% since, to $287 in 2025.
Across 65 payments — averaging $259.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- BD$2K
- Edwards Lifesciences$2K
- Davol Inc.$288
- Baxter Healthcare$142
- E.r. Squibb & Sons, L.L.C.$101
- plus $431 from 9 others
What the payments were for
- Travel & lodging$4,43826%
- Food & beverage$2,69016%
- Education$9,74958%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $12,580 |
| BD | 13 | $1,719 |
| Edwards Lifesciences | 9 | $1,632 |
| Davol Inc. | 4 | $288 |
| Baxter Healthcare | 2 | $142 |
| E.r. Squibb & Sons, L.L.C. | 1 | $101 |
| Astellas Pharma US Inc | 1 | $99 |
| AbbVie | 1 | $85 |
| GSK | 4 | $83 |
| Dilon Technologies, Inc. | 1 | $39 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Vertex | 2 | $33 |
| Alcresta Therapeutics, Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,821
- DAVINCI XI$5,500
- Phasix Mesh$1,330
- FLOSEAL$121
- ARISTA AH FLEXITIP$116
- Channel Drain$111
- Sotyktu$101
How this compares
$16,893 in reported general payments places this provider in the 80th percentile of 39 colon & rectal surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 23 | $1,402 |
| Ondansetron OdtOndansetron | 61 | $419 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 58 | $365 |
| Neomycin Sulfate | 18 | $118 |
| Metronidazole | 23 | $98 |
| Pantoprazole Sodium | 17 | $71 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Marrero
- Jennifer ParuchNew Orleans$63K
- Andrew WernerShreveport$22K
- Charles WhitlowNew Orleans$22K
- Brielle HebertShreveport$22K
- Jennifer SilinskyMetairie$21K
- Elyse Bevier-RawlsNew Orleans$18K
- Louis BarfieldBaton Rouge$17K
- Danielle KayNew Orleans$16K
- William JohnstonNew Orleans$15K
- Valentine NfonsamNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.